Hansa Investment Company Ltd Registered A Non-Voting

HANA

Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event

Tip Ranks

Hansa Investment Company Ltd

Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event

Hansa Investment Company Limited has announced the purchase of 68,000 of its own ordinary shares at a price of 282.00p each, which will be cancelled. Following this transaction, the remaining share capital includes 67,983,610 ordinary shares with voting rights and 131,954,920 ordinary 'A' shares without voting rights. This information is provided in accordance with the FCA's Disclosure Guidance and Transparency Rules.

London Stock Exchange

REG - Hansa Investment Co Hansa Invest-HANA - Transaction in Own Shares

Hansa Investment Company Limited announced its estimated unaudited Net Asset Value (NAV) for its Ordinary and 'A' Ordinary Shares as of February 26, 2026. The Cum Income NAV is 508.72p, while the Ex Income NAV is 505.70p. The NAV calculations follow the guidelines of the Association of Investment Companies (AIC), which advises listing NAVs both inclusive and exclusive of net income for the current period. This information is provided by RNS, the news service of the London Stock Exchange.

Hansard Global plc

REG - Hansa Investment Co Hansa Invest-HANA - Net Asset Value(s)

Hansa Investment Company Ltd 'A' (LON:HANA) reached a new 52-week high of GBX 280, closing at GBX 278 with a trading volume of 1,202,683 shares. The company has a market cap of £557.94 million and a P/E ratio of 14.40. Insider Simona Heidempergher purchased 12,000 shares at GBX 274. Analysts currently rate the stock as a Hold, suggesting there may be better investment options available.

Market Beat

Hansa Investment Company Ltd 'A' (LON:HANA) Hits New 1-Year High  - What's Next?

Hansa Investment Company Ltd 'A' (LON:HANA) insider Simona Heidempergher purchased 12,000 shares at an average price of GBX 274 per share, totaling £32,880. Following the transaction, shares opened at GBX 277.61, reflecting a 1.3% increase. The company has a market cap of £557.16 million and a price-to-earnings ratio of 14.38. Hansa Investment Company is a closed-ended equity fund that invests in global public equity markets, focusing on value stocks and small-cap companies.

Hansa Investment Company Ltd Registered A Non-Voting(HANA.UK)

Hansa Biopharma to Present Commercial Strategy at Redeye Life Science Event

REG - Hansa Investment Co Hansa Invest-HANA - Transaction in Own Shares

REG - Hansa Investment Co Hansa Invest-HANA - Net Asset Value(s)

Hansa Investment Company Ltd 'A' (LON:HANA) Hits New 1-Year High - What's Next?

Insider Buying: Hansa Investment Company Ltd 'A' (LON:HANA) Insider Acquires 12,000 Shares of Stock